Compare ENPH & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENPH | TMDX |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | United States |
| Employees | N/A | 728 |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.2B |
| IPO Year | 2012 | 2019 |
| Metric | ENPH | TMDX |
|---|---|---|
| Price | $33.87 | $122.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 24 | 8 |
| Target Price | $42.73 | ★ $144.25 |
| AVG Volume (30 Days) | ★ 5.6M | 664.3K |
| Earning Date | 02-03-2026 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 233.44 | 170.70 |
| EPS | 1.44 | ★ 2.54 |
| Revenue | ★ $1,512,377,000.00 | $566,354,000.00 |
| Revenue This Year | $12.30 | $38.81 |
| Revenue Next Year | N/A | $20.49 |
| P/E Ratio | ★ $22.23 | $47.97 |
| Revenue Growth | 20.97 | ★ 41.20 |
| 52 Week Low | $25.78 | $55.00 |
| 52 Week High | $76.90 | $156.00 |
| Indicator | ENPH | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 59.99 | 42.70 |
| Support Level | $31.70 | $121.00 |
| Resistance Level | $33.91 | $133.29 |
| Average True Range (ATR) | 1.26 | 4.77 |
| MACD | 0.08 | -0.83 |
| Stochastic Oscillator | 75.56 | 22.79 |
Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.